Behçet's disease is a complex, multisystem inflammatory disorder characterised by recurrent mucocutaneous lesions, ocular involvement, and vascular, neurological, and gastrointestinal manifestations.
PRINCETON, N.J., July 31, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...
(RTTNews) - Shares of Soligenix Inc. (SNGX) are up more than 20% at $1.50 in premarket hours, following encouraging results from its Phase 2a proof of concept study of SGX945 in the treatment of ...
In its February 2024 meeting, the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use has granted marketing authorizations for Pyzchiva (ustekinumab) for the treatment ...
Soligenix shares surged more than 50% in early trading Monday after the late-stage biopharmaceutical company won U.S. Food and Drug Administration orphan-drug designation for the active ingredient in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback